In this retrospective cohort study of a large population in Belgium, researchers aimed to examine endometrial cancer risk in patients with breast cancer who received tamoxifen.

Electronic data capture (EDC) extract from the ongoing ACR-368 registrational-intent Phase 2b monotherapy trial in OncoSignature-positive (BM+) subjects with endometrial cancer (EC) showed 39% overall ...

A previously unknown mechanism that makes it possible for aggressive so-called triple-negative breast cancer to fine-tune its ...

A new clinical study published in the International Journal of Gynecological Cancer reports encouraging results for women ...